Daniel Joseph McCarthy - 15 Sep 2022 Form 3 Insider Report for Evolent Health, Inc. (EVH)

Role
PRESIDENT
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
15 Sep 2022
Transactions value $
$0
Form type
3
Filing time
26 Sep 2022, 16:37:24 UTC
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EVH Class A Common Stock 168K 15 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EVH Class A Common Option (right to buy) 15 Sep 2022 Class A Common Stock 3K $10.65 Direct F2
holding EVH Class A Common Option (right to buy) 15 Sep 2022 Class A Common Stock 3.06K $18.25 Direct F3
holding EVH Class A Common Option (right to buy) 15 Sep 2022 Class A Common Stock 4.55K $24.75 Direct F4
holding EVH Class A Common Option (right to buy) 15 Sep 2022 Class A Common Stock 16.8K $13.95 Direct F5
holding EVH Class A Common Option (right to buy) 15 Sep 2022 Class A Common Stock 14.4K $13.29 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units granted to Mr. McCarthy pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan.
F2 12,000 options were granted on May 12, 2015 and vested and became exercisable ratably in four annual installments beginning on May 1, 2016. Prior to the date of the event requiring the filing of this Form 3, 3,000 of these options remain outstanding and have vested.
F3 3,064 options were granted on February 1, 2017 and vested and became exercisable ratably in four annual installments beginning on February 1, 2018.
F4 4,550 options were granted on August 1, 2017 and vested and became exercisable ratably in four annual installments beginning on August 1, 2018.
F5 16,835 options were granted on February 1, 2018 and vested and became exercisable ratably in four annual installments beginning on February 1, 2019.
F6 14,368 options were granted on March 1, 2019 and vest and become exercisable ratably in four annual installments beginning on March 1, 2020. Prior to the date of the event requiring the filing of this Form 3, 10,776 of these options had vested.

Remarks:

See Exhibit 24.1 - Power of Attorney